Skip to main content

Huston Associates, LLC

Scientific & Market Driven Biopharmaceutical Development Planning and Execution
Home
About Us
Biography
Industry Experience
Publications
Contact Us
Site Map
Publications, Presentations, and Abstracts

Publications

Barnes, DA, Huston, M and Perez, HD. TNF-a and IL-1b cross-sensitization of astrocytes and astrocytoma cell lines.

             J. Neuroimmunol, 1998 Vol 87:17-26.

 

Barnes, DA, Huston, M, Benveniste, EN, et al. Induction of RANTES expression by astrocytes and astrocytoma cell lines.

            J Neuroimmunol, 1996 Vol 71:207-14.

 

Lu HT, Huston M, Stark G and Ransohoff, R. Interferon-b acts downstream of IFN-g induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-g. J Exp Med, 1995.Vol 182(5): 1517-25.

 

Lee Y-J, Panek B, Huston M and Benveniste, EN. Role of protein kinase C and tyrosine kinase activity in IFN-g induced expression of the class II MHC gene. Am J Physiol, 1995.Vol 268 (1 pt 1): C127-37.

   

Chong KT and Huston M. Implications of endotoxin contamination in the evaluation of antibodies to lipopolysaccharides in a murine model of gram-negative sepsis. J Infect Disease, 1987, vol 156(5)

   

Rodgers G, Huston M, et al. Serological characterization of an E. coli expressed 37-kilodalton T. pallidum antigen and gene localization. Infect and Immun, July 1986

 

Hare JF and Huston M. Virosome-mediated implantation of red cell band 3 into the plasma membrane of cultured hepatoma cells .Exp Cell Research, 1985, vol. 161.

 

Hare JF and Huston M. Degradation of exogenous membrane proteins implanted into the plasma membranes of cultured hepatoma cells. Exp Cell Research, 1985, vol. 161

 

Hare JF and Huston M. Degradation of surface labeled hepatoma membrane polypeptides:Effects of inhibitors.Arch Biochem and Biophys, Sept. 1984.

 

ABSTRACTS and PRESENTATIONS

The Use of @RISK for Project in Biopharmaceutical Schedule Risk Assessment, Team Building and Strategic Planning. Palisade

             Health Risk Analysis Forum. San Diego, CA. Mar 31, 2010

 

eProtocols for eClinical Trials.With Hewlett-Packard.DIA E-Pharma Meeting: Enabling Clinical Research and Business in the

             Biopharmaceutical Industry.Philadelphia, PA.Oct 21, 2002

Applied Clinical Trials Conference.Clinical Team Decision Points (Oral Presentation). San Diego, CA.Sept. 29, 1999.

 

Williams GJ, Huston M, et al.Effects of BetaseronÒ on hepatitis B virus replication in HIV-infected individuals.J of Interferon Res, 1990.Vol 10, suppl 1:S14

 

Williams GJ, Huston M, et al.Correlation of increased serum neopterin levels and suppression of HIV p24 antigen in AIDS patients receiving BetaseronÒ and AZT therapy.J of Interferon Res, 1990.Vol 10, suppl 1:S105.

 

Langton B, Hancock M, Huston M, et al. The development and characterization of antibodies to different regions of the c-erb-B2 protein on breast tumor tissue and cell lines.Proc American Association of Cancer Research, 1989. Vol 30

 

Hare JF and Huston M. Metabolic degradation of the red cell anion transporter implanted into the plasma membrane of dividing hepatoma cells.UCLA Symbosia.J of Cellular Biochem, 1984 suppl 8A.

 

Hare JF, Huston M and Rich P. Differential turnover of exogenous membrane polypeptides implanted into the hepatoma cell membrane.UCLA Symposia, J of Cellular Biochem, 1983 Suppl 7B

 

Hare JF and Huston M. Virosome-mediated implantation of exogenous membrane protein into the plasma membrane of cultured hepatoma cells.FASEB/ASBC Proceedings, June 1983, San Francisco, CA